HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon Haydar Selected Research

1- (6- (4- fluorophenyl)pyridin- 3- yl)- 3- (4- piperidin- 1- ylbutyl)urea

12/2011Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon Haydar Research Topics

Disease

3Cognitive Dysfunction
05/2014 - 05/2009
2Schizophrenia (Dementia Praecox)
12/2011 - 05/2009
1Alzheimer Disease (Alzheimer's Disease)
05/2009

Drug/Important Bio-Agent (IBA)

2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2014 - 12/2011
2alpha7 Nicotinic Acetylcholine ReceptorIBA
12/2011 - 05/2009
1Antipsychotic Agents (Antipsychotics)IBA
12/2011
11- (6- (4- fluorophenyl)pyridin- 3- yl)- 3- (4- piperidin- 1- ylbutyl)ureaIBA
12/2011
15-morpholin-4-ylpentanoic acid (4-pyridin-3-ylphenyl)amideIBA
05/2009